ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 63 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $86,344 | -82.9% | 13,366 | -80.0% | 0.00% | – |
| Q1 2023 | $504,411 | -32.9% | 66,898 | -9.9% | 0.00% | – |
| Q4 2022 | $752,112 | -77.9% | 74,246 | -78.4% | 0.00% | -100.0% |
| Q3 2022 | $3,402,000 | +673.2% | 343,938 | +731.7% | 0.00% | – |
| Q2 2022 | $440,000 | -27.8% | 41,355 | -33.8% | 0.00% | – |
| Q1 2022 | $609,000 | -46.2% | 62,425 | -21.2% | 0.00% | – |
| Q4 2021 | $1,132,000 | -10.9% | 79,191 | +24.9% | 0.00% | – |
| Q3 2021 | $1,270,000 | +40.8% | 63,407 | +54.6% | 0.00% | – |
| Q2 2021 | $902,000 | +767.3% | 41,018 | +1236.5% | 0.00% | – |
| Q1 2021 | $104,000 | – | 3,069 | +38262.5% | 0.00% | – |
| Q4 2020 | $0 | – | 8 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
| Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
| Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
| Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
| Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
| Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
| Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
| Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |